Introduction
Flexible nasoendoscope decontamination has become a subject of immense importance and relevance, especially with regard to patient safety. To illustrate, over the last decade, flexible nasoendoscope has become an indispensable tool to otorhinolaryngologists. It has become part of the routine clinical examination, providing instant and clear visualization of the nasal cavity, pharynx, and larynx in the clinic setting. The average clinic uses the flexible nasoendoscope about 7 times in one session [1] . After each use, the flexible nasoendoscope needs to be decontaminated prior to its use on the next patient in order to avoid the risk of cross-infection among patients.
In recent years, contention has been raised regarding the need for centralization of the decontamination process [1, 2] . Current guidance advocates that the automated washer be operated in a centralized decontamination unit [3] . The rationale is that the automated washer has the advantage of being operated on a preset protocol, which is repeatable and can be regularly tested. The centralization of decontamination process also ensures that trained staff would be handling the decontamination process on a high-volume basis. Overall, this minimizes variability and potentiality for errors in the decontamination process. However, centralization of the decontamination process comes with its own set of problems, which include prolonged decontamination time necessitating additional purchase of scopes to cope with clinical turnover, additional costs and manpower for transport of scopes to a centralized unit [1] .
Most of the guidelines on flexible nasoendoscope decontamination are extrapolated from decontamination evidence of gastroscopes [1] . However, this application of evidence is flawed owing to the differences in nature of the procedures as well as the degree of contamination both types of scopes are exposed to. For instance, unlike gastroscopes, the most widely used flexible nasoendoscopes are those without biopsy channels. Secondly, unlike gastroscopy, flexible nasoendoscopy is also less liable to blood contamination. Hence, one may be able to argue that flexible nasoendoscopes without biopsy channels may not have to undergo a decontamination process as rigorous as that of gastroscopes, but still retain the clinical efficacy in preventing cross-contamination among patients, and at a cheaper cost.
Anioxyde 1000 is the regular, 5-minute decontamination process currently being used in our department. Although it has been proven effective as a decontaminating agent in laboratory studies, its efficacy in decontamination in the clinical setting has yet to be determined. It is important to prove efficacy in clinical use because the effectiveness of such decontamination agents is subjected to variables such as clinical demands for equipment turnover, the ease of use of the decontamination process, the effort being put into staff training, and the audit of clinical practices to ensure compliance with protocol. In this study, we will examine the efficacy and adequacy of our clinical decontamination practice.
Objective
The primary aim of our study is to examine the efficacy of flexible nasoendoscope decontamination utilizing the Anioxyde 1000 system and the automated washer in the clinical setting.
The secondary outcome measure is to examine the bio-burden of the flexible nasoendoscope following a scope procedure being done on patients. This will give us an idea of pathogenicity of the organisms and postulate the disease transmissibility of flexible nasoendoscopes.
Methods
This study received ethics approval from the Domain Specific Review Boards of National Healthcare Group, Singapore.
After routine use of the flexible nasoendoscope (Pentax® and Olympus® ) in adult patients in our General and Subspecialty Otolaryngology clinics, flexible nasoendoscopes were decontaminated as per our standard clinic protocol (Table 1) . Main decontamination process utilized is the soaking of flexible nasoendoscope in Anioxyde 1000. In accordance with the hospital guidelines, the flexible nasoendoscope is also decontaminated in an automated washer at the end of a workday.
Sterile microbiological cotton swabs were used to swab the flexible nasoendoscope tips and surface area up to 2 cm proximal to the tip, with numerous passes back and forth within this area, to ensure the maximal yield of each swab. This is the area of the scope that is in most consistent contact with the patient.
Swabs were taken sequentially in the decontamination workflow. Swab 1 was taken before flexible nasoendoscopy was performed. Swab 2 was taken after the flexible nasoendoscopy was performed on the patient (as shown in Figure 1 ). The subsequent swab 3 was taken after the flexible nasoendoscope was decontaminated with Anioxyde 1000.
Specifically for this trial (deviation from clinic workflow), the flexible nasoendoscopes were then further decontaminated with an automated washer to prevent any risk of cross-infection in our patients from potential inadequate Anioxyde 1000 decontamination. Swab 4 was taken after the flexible nasoendoscope was decontaminated with the automated washer.
The rationale for each swab is as follows:
• Swab 1 -this swab is taken before the flexible nasoendoscope is used on the patients. Any bacterial growth obtained from this swab will be a reflection of the adequacy of the storage practice for our flexible nasoendoscopes.
• Swab 2 -this swab is taken after the flexible nasoendoscope is used on the patients. This swab allows us to assess the bacteria yield on the nasoendoscopes after a routine flexible nasoendoscopy. This swab is also a positive control and will be compared with swab 3 and swab 4 (see below) to examine the decontamination efficacy of Anioxyde 1000 and automated washer.
• Swab 3 -this swab is taken after nasoendoscope is decontaminated with Anioxyde 1000. The difference of bacterial growth between swab 2 and 3 will allow an assessment of decontamination efficacy of Anioxyde 1000.
• Swab 4 -this swab is taken after nasoendoscope is decontaminated with an automated washer. The difference of bacterial growth between swab 2 and 4 will allow an assessment of decontamination efficacy of the automated washer. In addition, this swab allows us to compare the Anioxyde 1000 efficacy against that of the automated washer.
Anioxyde 1000 Anioxyde 1000 is a high-level decontamination agent that contains extemporaneous production of peracetic acid from acetylcaprolactam (PHERA system) and 3% hydrogen peroxide. It is bactericidal, fungicidal, virucidal and sporicidal within a contact time of 5 minutes [6] .
Microbiological Swab Processing Protocol After sampling, the swab was inoculated into 10 ml of brain-heart infusion broth (BHIB) and vortexed for 30 seconds. It was then incubated at 35°C for 7 days. The broth was observed for turbidity every other day up to Day 7. The broth was sub-cultured onto of blood agar (BA) and incubated at 35°C ambient air, if turbidity was noted. Organisms grown were identified using the Bruker MALDI Biotyper mass spectrometer (MALDI-TOFMS). If broth was clear by Day 7, it was reported as no growth. 
1.
Use of flexible nasoendoscope on the patient.
2.
Flexible nasoendoscope is transported in a non-sterile box (labeled 'dirty') by ENT Clinic staff to a decontamination room within the ENT Clinic (area isolated from the clinical area).
3.
Flexible nasoendoscope is rinsed thoroughly under the running tap for removal of visible residues (mucus/saliva/pus/blood).
4.
Flexible nasoendoscope is soaked in a basin of Anioxyde 1000 for 5 minutes (timer used).
5.
Flexible nasoendoscope is rinsed in a basin of sterile water (changed twice a day) to remove any Anioxyde 1000 residue.
6.
Flexible nasoendoscope is wiped dry with non-sterile clean tissue.
7.
Flexible nasoendoscope is stored in a clean non-sterile box (labeled 'clean') and transported back into clinic room for use in next patient.
8.
At the end of a workday, at 4.30 pm, flexible nasoendoscope is placed in an automated washer (utilizes Anioxyde 1000 as decontamination solution) for 30 minutes.
9.
Flexible nasoendoscope is wiped dry with a non-sterile clean tissue.
10. Flexible nasoendoscope is stored in a dry non-sterile metal cupboard. 
Results
A total of 60 sets of swabs were taken sequentially as the decontamination process was carried out. Swab 1 showed 6/60 growth (10%). The profile of bacterial growth isolated is as below ( Table 2) .
Swab 2 showed 57/60 growth (95%). Some swabs showed more than one type of bacterial isolate. The profile of bacterial growth isolated is as below (Table 3) . Swab 3 showed 6/60 growth (10%). The profile of bacterial growth isolated is as below ( Table 4) . Out of the 6 growth isolated, none of these were the same organism isolated from the corresponding swab 2.
Swab 4 showed 4/60 growth (7%). Out of the 4 growth isolated, none of these were the same organism isolated from the corresponding swab 2 and swab 3. The profile of bacteria growth isolated is as below (Table 5) .
Anioxyde 1000 (swab 3) is efficacious in decontamination compared to that of the positive control (swab 2) (p=0.000 McNemar's Test). Similarly, automated washer (swab 4) is efficacious in eliminating bacterial growth when compared to positive control (swab 2) (p=0.000 McNemar's Test). There was no statistical significance in the decontamination efficacy of Anioxyde 1000 (swab 3) and automated washer (swab 4) (p = 0.727
McNemar's Test).
There was no damage to nasoendoscopes sustained as a result of the decontamination process during the study period.
Discussion
The regular use and rapid turnover of flexible nasoendoscopes in the clinic setting pose a potential risk of cross infection. This is because an inadequately decontaminated flexible nasoendoscope serves as a potential avenue for disease transmission from one patient to another. Our study aims to investigate this element of healthcare.
It is most important to note that the flexible nasoendoscope decontamination process is a non-sterile process. From the storage, handling, and clinical use, to the decontamination of the scopes, for practical reasons, it is not done in an aseptic manner. Traditionally, there has not been any requirement for flexible nasoendoscopes to be stored in a sterile environment. It is advocated that it should be stored by hanging it vertically in a dry clean cupboard [4] . However, the safety of such practice was not previously investigated. Our study demonstrated minimal non-pathogenic environmental growth on our flexible nasoendoscope with nonsterile storage. This demonstrates that it is both practical and adequate for flexible nasoendoscopes to be stored in a non-sterile but clean and dry environment.
Swab 2 is taken after the flexible nasoendoscopy is performed on the patient and before any decontamination is done. In this study, it functions as a positive control. In addition, swab 2 also reflects the bio-burden on the flexible nasoendoscopes following routine flexible nasoendoscopy. In our study, Coagulase Negative Staphylococci, Staphylococcus aureus, and Staphylococcus epidermidis were the commonest isolates on flexible nasoendoscopes following the process of flexible nasoendoscopy on our ENT patients. These are similar to the organisms found in the normal flora of upper respiratory tract as shown by Jousimies-Somer et al [5] .
Our study also showed that there were no spore-forming bacteria or strict pathogens (pathogens that can infect all human hosts who are exposed to it such as Mycobacterium tuberculosis, Treponema pallidum, Plasmodium, Neisseria gonorrhoeae) isolated following routine flexible nasoendoscopy. This finding has clinical implications in rationalizing the use of high-level disinfection in flexible nasoendoscope decontamination. Controversies exist with regard to whether healthcare instruments should be sterilized or high-level disinfected. Although high-level disinfection is deemed as the standard and adequate decontamination process utilized for flexible nasoendoscopes [6] , it has the disadvantage of not being able to eliminate bacterial spores. Yet, many scopes used in the clinical setting, including the flexible nasoendoscopes, are heat sensitive and cannot undergo sterilization. In our study, the low pathogenicity of organisms and absence of spore-forming bacteria isolated from our flexible nasoendoscopes following use in patients suggest that high-level disinfection is adequate. This is further supported by the absence of reports of cross-infection from flexible nasoendoscope use. Unlike some of the other recent studies [7] [8] [9] , some of our swabs (swab 3 and 4) showed some bacterial growths following decontamination with Anioxyde 1000 and automated washer. However, none of these growths are bacterial isolates from the corresponding swab 2. This suggests that the decontamination process was indeed effective in removing the bacteria following flexible nasoendoscopy. However, the different bacterial growth isolated from swab 3 and swab 4 suggests environmental origins of these contaminants. Given that the decontamination process is not done entirely in a sterile manner, it is plausible that the contaminants could originate from non-sterile gloves or from airborne contaminants (staff sneezing/coughing).
In recent years, there has been an increased movement towards the use of automated washer in a centralized decontamination unit in order to reduce processing error from human variability. However, the recently published studies showed that simple and quicker decontamination processes were as efficacious in decontamination compared with the automated washer [7, 8] . Liming et al demonstrated that '30-second 70% isopropanol + antimicrobial soap scrub' or a '12-minute Cidex OPA soak' is just as effective as the '30-minute run in an automated endoscope reprocessor' [8] . Our results demonstrated that the 5-minute Anioxyde 1000 soak used in the clinic and a non-centralized decontamination setting are effective in bacterial elimination. The emergence of such clinical evidence demonstrating equal efficacy of these shorter and simpler decontamination protocols has potential implication in driving the decontamination process towards less time-consuming methods. This could help alleviate the manpower burden required to transport the scopes to the automated washer. At the same time, it obviates the necessity to purchase more flexible nasoendoscopes to cope with the prolonged automated washing process and rapid clinical turnover.
One of the limitations of our study is the lack of investigation into fungal and virus growth in the decontamination process. This would have provided a more complete picture of the bio-burden on the flexible nasoendoscope following the procedure and thus presented a clearer picture on the disease transmissibility of a routine flexible naso-endoscopy procedure. This limitation is due to cost constraints. However, it is important to note that Peracetic acid has been shown to inactivate fungi, yeast, and virus and eliminate spores effectively in the in vivo setting [10] . In addition, a previous clinical study has demonstrated low fungal contamination from the flexible nasoendoscope following the scope procedure [7] .
Another area that could be evolved from our study is that the microbiological swabs can be taken from consecutive patients. As a proposed study for future, testing of decontamination efficacy in sequential patients will be helpful to evaluate the disease transmissibility of flexible nasoendoscopes following inadequate decontamination.
Conclusion
Our existing clinical decontamination process with a 5-minute soak of Anioxyde 1000 is effective. It is adequate for flexible nasoendoscopes to be stored in a non-sterile but clean and dry environment. Bio-burden testing of flexible nasoendoscope showed similar growth to that of the organ isms found in the normal flora of upper respiratory tract. However, virus, fungi and sporicidal growth were not investigated in our study. Hence, the full spectrum of bio-burden of flexible nasoendoscopy requires further examination.
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